Posts in category Economic Times
Bitcoin slumps 8% after Iran attacks Israel, flashes warning for global markets (14-04-2024)
The largest cryptocurrency slid 7.7% on Saturday, the biggest such retreat since March 2023. The token pared some of the drop to change hands at about $63,230 as of 11:36 a.m. in Singapore on Sunday. Most other major coins such as Ether, Solana and meme-crowd favorite Dogecoin nursed 24-hour losses.
Israel-Iran conflict, Q4 earnings among 11 factors that will steer D-Street this week (14-04-2024)
The upcoming week promises to show top action with the Iran-Israel conflict taking center stage along with the earnings season which kicked off with the announcement of earnings by TCS. Oil prices, China GDP data, US retail sales figures, and movements in US bond yields and the dollar index will be important macroeconomic events that may influence market sentiments
Hold Sun Pharma and Dr Reddy’s; buy Natco on dips among pharma stocks: Mayuresh Joshi (14-04-2024)
Mayuresh Joshi shares insights on pharma and telecom sectors, focusing on key players like Sun Pharma, Dr Reddy's, Bharti Hexacom, and Exide. The discussion also includes Vodafone's FPO and the potential of Li-Ion battery makers.
Slightly bearish on the market; if you have raised cash, stay on the sidelines: Sanjiv Bhasin (14-04-2024)
Sanjiv Bhasin discusses Vodafone Idea's resilience, market cap, and long-term potential in the telecom sector. He says promoter's investment in Vodfone IDEA showcases confidence amidst challenges. The focus is on survival, growth through capex, and market share retention for sustained performance. Overall, Bhasin says he is slightly bearish on the market. "I would advocate that if you have raised cash, then stay on the sidelines. "
Enough ideas to invest in even when market is at record high; betting on 3 sectors: Mukul Kochhar (14-04-2024)
Mukul Kochhar suggests going overweight on autos, financials, and pharma. He is positive on PSU as well as private banks based on their valuations. There is a preference for two-wheelers due to stability. The pharma sector is expected to outperform with pricing power. He remains underweight on cement, core FMCG, and IT sectors.
As Vi Speak: Telco to ring in biggest FPO of Rs18,000 crore (13-04-2024)
Issue priced at Rs10-11 a share; at higher end, FPO is at 26% discount to preferential issue.
Emerging-market bulls tout Modi premium as election nears (13-04-2024)
Investors remain bullish on India's stock market performance under Prime Minister Narendra Modi's govt, anticipating stability, growth, and continued attractiveness to global funds. Modi's focus on manufacturing, infrastructure, and addressing electorate concerns are key expectations.
Dalal Street Week Ahead: Market momentum likely to fade, time to protect profits (13-04-2024)
The markets may see a soft start to the week on Monday. The levels of 22650 and 22775 are likely to act as potential resistance points. The supports come in at 22400 and22280 levels.
Is it time to buy healthcare stocks? Rajesh Palviya weighs in (13-04-2024)
“Till Nifty is holding about 22,500, 22,400, trend is likely to remain on the bullish side and buy on dip should be your strategy. On the higher side, once again, Nifty spot manages to cross above 22,650, 22,700, then this rally can extend further and a possible target we could see towards the 22,800 to 23,000 level.”